ACI Group

ACI Limited, commonly known as ACI Group, is a leading pharmaceutical and biotechnology conglomerate headquartered in Bangladesh. The company operates through several specialized divisions, including ACI Pharmaceuticals and ACI Biotech, focusing on the development, manufacturing, and commercialization of a broad range of therapeutic products. Its portfolio encompasses generic small molecules, biosimilars, and vaccines, addressing critical needs in oncology, endocrinology, and infectious diseases. ACI maintains state-of-the-art manufacturing facilities that adhere to international quality standards, enabling it to serve both domestic and global markets. The company's strategic expansion into high-value biologicals, such as monoclonal antibodies and recombinant proteins, positions it as a key player in the regional healthcare landscape.